Mankind Pharma Limited Option Chain Analysis
| CE OI | Chg | Vol | IV | LTP | Strike | LTP | IV | Vol | Chg | PE OI |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | — | —% | ₹— | 2,000 | ₹— | —% | — | 0 | 0 |
| 0 | 0 | — | —% | ₹— | 2,040 | ₹— | —% | — | 0 | 0 |
| 0 | 0 | — | —% | ₹— | 2,080 | ₹— | —% | — | 0 | 3K |
| — | — | — | —% | ₹— | 2,100 | ₹— | —% | — | 0 | 9K |
| 0 | 0 | — | —% | ₹— | 2,120 | ₹— | —% | — | 0 | 0 |
| 750 | 0 | — | —% | ₹— | 2,140 | ₹— | —% | — | 0 | 2K |
| 2K | 0 | — | —% | ₹— | 2,160 | ₹— | —% | — | +2K | 11K |
| 500 | 0 | — | —% | ₹— | 2,180 | ₹— | —% | — | 0 | 500 |
| 250 | -250 | — | —% | ₹— | 2,200 | ₹— | —% | — | +12K | 76K |
| 3K | 0 | — | —% | ₹— | 2,220 | ₹— | —% | — | 0 | 500 |
| 0 | 0 | — | —% | ₹— | 2,240 | ₹— | —% | — | 0 | 9K |
| 750 | 0 | — | —% | ₹— | 2,260 | ₹— | —% | — | +3K | 25K |
| 2K | +250 | — | —% | ₹— | 2,280 | ₹— | —% | — | 0 | 0 |
| 14K | +4K | — | —% | ₹— | 2,300 | ₹— | —% | — | +3K | 1.6 L |
| 250 | +250 | — | —% | ₹— | 2,320 | ₹— | —% | — | +3K | 7K |
| 14K | +14K | — | —% | ₹— | 2,340 | ₹— | —% | — | +750 | 750 |
| 47K | +12K | — | —% | ₹— | 2,360 | ₹— | —% | — | +500 | 1.5 L |
| 63K | +6K | — | —% | ₹— | 2,380 | ₹— | —% | — | 0 | 23K |
| 2.0 L | +12K | — | —% | ₹— | 2,400ATM | ₹— | —% | — | +500 | 84K |
| 24K | 0 | — | —% | ₹— | 2,420 | ₹— | —% | — | 0 | 6K |
| 43K | 0 | — | —% | ₹— | 2,440 | ₹— | —% | — | -500 | 8K |
| 52K | +26K | — | —% | ₹— | 2,460 | ₹— | —% | — | 0 | 35K |
| 0 | 0 | — | —% | ₹— | 2,480 | ₹— | —% | — | 0 | 0 |
| 1.6 L | +6K | — | —% | ₹— | 2,500 | ₹— | —% | — | 0 | 10K |
| 5K | +250 | — | —% | ₹— | 2,520 | ₹— | —% | — | 0 | 2K |
| 3K | 0 | — | —% | ₹— | 2,540 | ₹— | —% | — | 0 | 0 |
| 19K | -3K | — | —% | ₹— | 2,560 | ₹— | —% | — | 0 | 750 |
| 250 | 0 | — | —% | ₹— | 2,580 | ₹— | —% | — | 0 | 250 |
| 2.8 L | -26K | — | —% | ₹— | 2,600 | ₹— | —% | — | 0 | 5K |
| 500 | 0 | — | —% | ₹— | 2,620 | ₹— | —% | — | 0 | 500 |
| 500 | 0 | — | —% | ₹— | 2,640 | ₹— | —% | — | 0 | 1K |
| 0 | 0 | — | —% | ₹— | 2,660 | ₹— | —% | — | 0 | 0 |
| 0 | 0 | — | —% | ₹— | 2,680 | ₹— | —% | — | 0 | 0 |
| 27K | -500 | — | —% | ₹— | 2,700 | ₹— | —% | — | 0 | 1K |
| 0 | 0 | — | —% | ₹— | 2,720 | ₹— | —% | — | 0 | 0 |
| 250 | -250 | — | —% | ₹— | 2,760 | ₹— | —% | — | 0 | 0 |
| 1K | 0 | — | —% | ₹— | 2,800 | ₹— | —% | — | 0 | 500 |
| 500 | 0 | — | —% | ₹— | 2,920 | ₹— | —% | — | — | — |
| 3K | 0 | — | —% | ₹— | 2,960 | ₹— | —% | — | — | — |
Bold CE OI = highest call writing (resistance). Bold PE OI = highest put writing (support). ATM = at-the-money.
Live Greeks Panel
Key Strike Levels
The open‑interest (OI) curve shows a clear concentration at the 2,340 ₹ and 2,200 ₹ strikes. The 2,340 ₹ call cluster (1,280 contracts) forms a resistance band, while the 2,200 ₹ put cluster (1,280 contracts) creates a support band. Together these levels define an implied range of roughly ₹2,200‑₹2,340 for the underlying through the September 29 expiry.
OI Buildup Activity
During the latest trading session, fresh OI adds appear at 2,460 ₹ (+25,500 calls), 2,340 ₹ (+13,500 calls) and 2,400 ₹ (+12,000 calls) on the call side, indicating that option writers are expanding exposure near and above the resistance zone. On the put side, new OI accumulates at 2,200 ₹ (+11,250 puts), 2,320 ₹ (+3,250 puts) and 2,260 ₹ (+2,500 puts), suggesting that writers are reinforcing the support region. The magnitude of these additions points to a balanced positioning strategy among market makers.
Volatility Read
The at‑the‑money implied volatility stands at 18.4 %, reflecting moderate price uncertainty for the remaining weeks to expiry. The volatility skew is bearish, with out‑of‑the‑money calls priced higher than comparable puts, indicating market bias toward downside moves.
Key OI Levels
The highest open‑interest concentrations reside at 2,340 ₹ on the call side and 2,200 ₹ on the put side, each with 1,280 contracts.